Picture of ASAHI KASEI logo

3407 — ASAHI KASEI News Story

0.000.00%
jp flag iconLast trade - 00:00
Basic MaterialsBalancedLarge CapSuper Stock

Brief: Vectivbio And Asahi Kasei Pharma Announce The Start Of A Phase 1 Study Of Apraglutide In Japan

March 13 (Reuters) - Asahi Kasei Corp  3407.T :
    * VECTIVBIO AND ASAHI KASEI PHARMA ANNOUNCE THE START OF A
PHASE
1 STUDY OF APRAGLUTIDE IN JAPAN

Source text for Eikon:  ID:nGNXX5gw0 
Further company coverage:  3407.T 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on ASAHI KASEI

See all news